Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Martin Whyte, Associate Professor of Metabolic Medicine, University of Surrey

Weight loss drug semaglutide shown to be safe and potentialy more effective at higher dose – new findings

These were the first trials to examine the effects of a 7.2mg dose of semaglutide on body weight. Caroline Ruda/ Shutterstock

A higher dose of the weight loss drug semaglutide (better known by its brand name Wegovy) may help people lose up to 25% of their body weight – without the risk of severe side-effects. These findings are based on the results of two recently published clinical trials.

Semaglutide has proven to be effective in helping people lose weight. But weight loss tends to plateau after about one year of use – even when taking the highest approved dose of the drug. This means patients may not reach their weight loss goals.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.